ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion.

Crispr-Edited Pancreatic Cells Successfully Transplanted in Type 1 Diabetes Patient for the First Time

For the first time, researchers have successfully implanted Crispr-edited pancreatic cells into a patient with type 1 diabetes. The gene-edi

NHS rolls out teplizumab immunotherapy to delay type 1 diabetes onset by three years

The NHS is rolling out teplizumab, an immunotherapy drug that delays the onset of type 1 diabetes by an average of three years in children a

Single DNA injection shows long-lasting weight loss and glucose control in mouse study

Scientists at The Wistar Institute have demonstrated that a single injection of a circular DNA molecule (a plasmid) can produce weight loss

10 out of 12 people cured in Type 1 Diabetes Study

Polyadenylation of insulin mRNA by Tent5a regulates pancreatic beta cells

Phase 1 trial finds triple monoclonal antibody combination safe and effective for HIV-1 prevention

This phase 1, multicentre, randomised, open-label trial (HVTN 140/HPTN 101 part B) evaluated the safety, pharmacokinetics, and neutralisatio